The global cutaneous T-cell lymphoma management landscape is undergoing rapid evolution due to progresses in investigation. A wide range of {therapeuticapproaches are now available, spanning traditional regimens such as topical drugs and phototherapy, to more advanced therapies like targeted therapy. Furthermore, clinical trials are continually ass